• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：靶向PIK3CG联合紫杉醇作为Claudin低表达型乳腺癌的潜在治疗方案[勘误]

Erratum: Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum].

出版信息

Cancer Manag Res. 2020 May 12;12:3331-3332. doi: 10.2147/CMAR.S260280. eCollection 2020.

DOI:10.2147/CMAR.S260280
PMID:32494196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7234805/
Abstract

[This corrects the article DOI: 10.2147/CMAR.S250171.].

摘要

[本文更正了文章的数字对象标识符：10.2147/CMAR.S250171。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb32/7234805/39ecc9530c43/CMAR-12-3331-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb32/7234805/39ecc9530c43/CMAR-12-3331-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb32/7234805/39ecc9530c43/CMAR-12-3331-g0001.jpg

相似文献

1
Erratum: Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum].勘误：靶向PIK3CG联合紫杉醇作为Claudin低表达型乳腺癌的潜在治疗方案[勘误]
Cancer Manag Res. 2020 May 12;12:3331-3332. doi: 10.2147/CMAR.S260280. eCollection 2020.
2
Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer.在Claudin低表达型乳腺癌中，将PIK3CG作为靶点与紫杉醇联合使用作为一种潜在的治疗方案。
Cancer Manag Res. 2020 Apr 20;12:2641-2651. doi: 10.2147/CMAR.S250171. eCollection 2020.
3
Erratum: Integrative Gene Expression Profiling Reveals That Dysregulated Triple microRNAs Confer Paclitaxel Resistance in Non-Small Cell Lung Cancer via Cotargeting MAPT [Corrigendum].勘误：整合基因表达谱分析显示失调的三联体微小RNA通过共同靶向微管相关蛋白tau（MAPT）赋予非小细胞肺癌对紫杉醇的抗性[勘误说明]
Cancer Manag Res. 2020 Dec 16;12:12915-12916. doi: 10.2147/CMAR.S293923. eCollection 2020.
4
Erratum: Risk Assessment for Breast Cancer Development and Its Clinical Impact on Screening Performance in Iranian Women [Corrigendum].勘误：伊朗女性乳腺癌发生的风险评估及其对筛查性能的临床影响[更正]。
Cancer Manag Res. 2021 Apr 8;13:3079. doi: 10.2147/CMAR.S311176. eCollection 2021.
5
Erratum: Sp1 Contributes to Radioresistance of Cervical Cancer Through Targeting G2/M Cell Cycle Checkpoint CDK1 [Corrigendum].勘误：Sp1通过靶向G2/M细胞周期检查点CDK1促进宫颈癌的放射抗性[更正]。
Cancer Manag Res. 2021 Nov 15;13:8525-8526. doi: 10.2147/CMAR.S348374. eCollection 2021.
6
Erratum: Circular RNA Profiling Reveals That circRNA_104433 Regulates Cell Growth by Targeting miR-497-5p in Gastric Cancer [Corrigendum].勘误：环状RNA分析揭示circRNA_104433通过靶向miR-497-5p调控胃癌细胞生长[更正]
Cancer Manag Res. 2020 Oct 8;12:9721-9724. doi: 10.2147/CMAR.S284696. eCollection 2020.
7
Erratum: Intraoperative Prediction of Non-Sentinel Lymph Node Metastasis Based on the Molecular Assay in Breast Cancer Patients [Corrigendum].勘误：基于分子检测对乳腺癌患者非前哨淋巴结转移的术中预测[更正]。
Cancer Manag Res. 2020 Mar 12;12:1875. doi: 10.2147/CMAR.S252297. eCollection 2020.
8
Erratum: CircFLNA Acts as a Sponge of miR-646 to Facilitate the Proliferation, Metastasis, Glycolysis, and Apoptosis Inhibition of Gastric Cancer by Targeting PFKFB2 [Corrigendum].勘误：环状肌动蛋白结合蛋白A（CircFLNA）作为miR - 646的海绵，通过靶向6 - 磷酸果糖 - 2 - 激酶/果糖 - 2,6 - 二磷酸酶2（PFKFB2）促进胃癌的增殖、转移、糖酵解及抑制细胞凋亡[更正]。
Cancer Manag Res. 2021 Jan 25;13:643. doi: 10.2147/CMAR.S302743. eCollection 2021.
9
Erratum: Long Intergenic Non-Coding RNA 01121 Promotes Breast Cancer Cell Proliferation, Migration, and Invasion via the miR-150-5p/HMGA2 Axis [Corrigendum].勘误：长链基因间非编码RNA 01121通过miR-150-5p/HMGA2轴促进乳腺癌细胞增殖、迁移和侵袭[更正]。
Cancer Manag Res. 2022 Mar 29;14:1283-1284. doi: 10.2147/CMAR.S367475. eCollection 2022.
10
Erratum: Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum].勘误：冬凌草甲素通过靶向Akt信号通路使肝癌细胞对索拉非尼的抗癌作用敏感 [更正]
Cancer Manag Res. 2021 Mar 16;13:2515. doi: 10.2147/CMAR.S310256. eCollection 2021.

引用本文的文献

1
Risk prediction model of uterine corpus endometrial carcinoma based on immune-related genes.基于免疫相关基因的子宫体子宫内膜癌风险预测模型。
BMC Womens Health. 2024 Jul 27;24(1):429. doi: 10.1186/s12905-024-03237-2.